|
|
| | Rivaroxaban iMpurity A Basic information |
| Product Name: | Rivaroxaban iMpurity A | | Synonyms: | Rivaroxaban Impurity 15;Rivaroxaban impurity G: Rivaroxaban ring opener;Rivaroxaban Acetoxalamide impurity;Rivaroxaban M;Rivaroxaban Open-Ring Acid Impurity;Rivaroxaban Impurity 11/(S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid;Rivaroxaban iMpurity A;2-({4-[(5S)-5-({[(5-chloro-2-thienyl)carbonyl]amino}methyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}-amino)ethoxyacetic acid | | CAS: | 931204-39-6 | | MF: | C19H20ClN3O6S | | MW: | 453.9 | | EINECS: | | | Product Categories: | | | Mol File: | 931204-39-6.mol |  |
| | Rivaroxaban iMpurity A Chemical Properties |
| Boiling point | 736.8±60.0 °C(Predicted) | | density | 1.470±0.06 g/cm3(Predicted) | | storage temp. | -10 to -25°C | | pka | 3.25±0.10(Predicted) | | Appearance | White to off-white Solid | | Major Application | pharmaceutical small molecule |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | Rivaroxaban iMpurity A Usage And Synthesis |
| Uses | An impurity of Rivaroxaban (R538000), a novel antithrombotic agent. A highly potent and selective, direct FXa inhibitor. |
| | Rivaroxaban iMpurity A Preparation Products And Raw materials |
|